Not known Factual Statements About Pam3CSK4 TFA (112208-00-1 free base)
Given that Pirfenidone is metabolised from the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy is to be avoided.Use of powerful CYP1A2 inhibitors must be discontinued just before initiating cure and prevented all through procedure; if strong CYP1A2 inhibitor is onl